Trial site
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
- 11running trials
- 4closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer2 trials
- Haemophilia2 trials
- Cervical cancer1 trial
- Chronic myeloid leukaemia1 trial
- IgA nephropathy1 trial
- Immune thrombocytopenia (ITP)1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Rheumatoid arthritis1 trial
- Stroke1 trial
- and 2 more
- Phase
- Phase 38 trials
- Phase 25 trials
- Status
- Active, not recruiting6 trials
- Recruiting5 trials
- Completed4 trials
- Lead sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology3 trials
- Hangzhou Gensciences Biopharmaceutical Co., Ltd.2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Changchun GeneScience Pharmaceutical Co., Ltd.1 trial
- Eisai Co., Ltd.1 trial
- and 6 more
Running trials
Recruiting
Endovascular Treatment for Posterior Circulation Ischemic Stroke Post 1 Day (24 Hours)
Active, not recruiting
Active, not recruiting
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Recruiting
Recruiting
Active, not recruiting
Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic myeloid leukaemia1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Rheumatoid arthritis1 recruiting
- Stroke1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
Completed
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026